Jump to content
Chapala.com Webboard

snowyco

Members
  • Content Count

    1,499
  • Joined

  • Last visited

  • Days Won

    7

snowyco last won the day on August 12 2016

snowyco had the most liked content!

Community Reputation

231 Excellent

1 Follower

About snowyco

  • Rank
    Advanced Member

Recent Profile Visitors

2,820 profile views
  1. We live in Yucatan, not far from Campeche. We got Sinovac in Campeche. ... Both of us are Mex. citizens, over age 60. Merida is doing Oxford-AstraZenica at some sites and Sinovac at others. In the north Yucatan beach coast areas they used only Pfizer's vaccine.
  2. ?? We got our first Sinovac vaccination 26 days ago, and we got our text message - scheduling us to get our second Sinovac jab on Saturday. Everyone we know who have gotten a 1'st jab here in Mexico, have been called back for their second shot.
  3. Here's the Brazilians "10,000 person study", that has only 85 vaccinated patients in the key COVID Treatment group used to calculate the Sinovac's %Efficacy ... and just 168 unvaccinated patients in the key Control COVID group used to report Sinovac's %Efficacy report of"50.7%" Efficacy. https://static.poder360.com.br/2021/04/estudo-preliminar-coronavac-11.abr_.2021.pdf Compare that way-too-small Brazilian study with just 86 vaccinated patients used to report %Efficacy, versus the larger Sinovac trials in Turkey that got 84% Efficacy for Sinovac's "Coronavac". https://www.reu
  4. The latest results for the Brazilian "Phase III" trial results for Sinovac's "Coronavac" are in ... and the results reveal a poorly conducted study with only a tiny group of just " 85 COVID cases ... in the vaccine group" and a trivial "168 COVID cases" in the placebo-Control group. Who believes a study that has just 85 patients in the Treatment Group (vaccinated patients) and a paltry 168 patients in the Control group for the key %Efficacy report ? Seriously ... Why believe the NY Times and AP and other Big Media source talking heads who only repeat the HEADLINE of "50.7% Low Ef
  5. The latest results for the Brazilian "Phase III" trial results for Sinovac's "Coronavac" are in ... and the results reveal a poorly conducted study with only a tiny group of just " 85 COVID cases ... in the vaccine group" and a trivial "168 COVID cases" in the placebo-Control group. Who believes a study that has just 85 patients in the Treatment Group (vaccinated patients) and a paltry 168 patients in the Control group for the key %Efficacy report ? Seriously ... Why believe the NY Times and AP and other Big Media source talking heads who only repeat the HEADLINE of "50.7% Low Ef
  6. Notice that when the New England Journal of Medicine reports that 22% of vaccinated people with COVID infections had "severe COVID disease" ... with up to 45% of them being hospitalized after 2 doses of Pfizer vaccine, THIS IS A NEW FINDING... not reported by Pfizer. Notice that when up to 12% of vaccinated patients GOT COVID ... "at 7 or more days after the second dose" ... it means the vaccine did not work up to 12% of the time. As such, the New England Journal of Medicine report results are NOT for your claimed supposed "21 days " or less after the 2'nd dose.
  7. So... AndyPanda trusts a Brazilian study, that had just 88 vaccinated patients in the Vaccine's %Efficacy group? Why? ... Because "the NY Times says so" ... ? Think about it for a moment: 88 patients is simply too small to provide a valid result for a vaccine efficacy trial.
  8. Believe the scientific posts out of the New England Journal of Medicine instead. Believe the scientific reports for the 10,000 patient Sinovac study performed in Turkey that reported 84% efficacy for the Sinovac. Why would anyone believe a Brazilian study of just "50% efficacy", that had just 88 vaccinated patients in the Treatment Group for calculating the vaccine % efficacy? ... Just because the NY Times & AP guys repeat it? Why would anyone believe a Brazilian study of just "50% efficacy", that had just 175 unvaccinated patients in the Control Group for calculating th
  9. The NY Times and AP are not scientific journals. The "50%" was not quoted from a Chinese Medican official, the "50%" value comes from a very small unreliable Brazilian study. Sadly, the NY Times & AP are unable to read & interpret scientific studies, unable to tell the difference between a good valid study versus a poor small study. The bigger 10,000 patient Turkish study showed Sinovac 83.5% efficacy, and Sinovac was 100% effective in stopping severe illness & hospitalization. ... and there were no significant side effects. https://www.reuters.com/article/health-coronavir
  10. Note the "50% efficacy " research report that the NY Times quotes & that the AP site quotes HAS ONLY 88 TOTAL PATIENTS in the Treatment Group (vaccinated patients) with COVID ... and just 175 TOTAL PATIENTS in the Control Group (unvaccinated patients) with COVID. No good scientist anywhere trusts tiny-study results that have just 88 Treatment (vaccinated) patients ... and 175 Control (unvaccinated) patients in their study from Brazil. The "50% " report is scientifically invalid ... and medically invalid ... because the study was so small. The bigger 10,000
  11. By definition, Medians have alway been averages. Read a basic dictionary: "The median is another form of an average." https://www.dictionary.com/e/average-vs-mean-vs-median-vs-mode/#:~:text=What is the median%3F,when it's ordered by rank. But that is not the point. The minor point, Bisbeegal, is that when human data sets are very large (like the Israeli data for over 1 million patients), and when they are normal distributions, then, with 95% Confidence: ½ the people in the big study have results below the "Average" (arithmatic mean) and ½ the people in the big study ha
  12. Think back to normal distributions and the Central Limit Theorem for very large data sets of over 1 million individuals. You are quoting a High School level math oversimplified definition, which ignores what a 1.6% RSD means for a symmetrical normal distribution. Readers can note that ALL Medians are "Average" values... just as ALL Means are "Average" values. "Average" is the overall umbrella term, that literally means 'central value' or 'central tendency' ... which can be either a Mean or a Median.... With over 1 million patients, and a tiny 1.6% RSD, and a symmetrical 88% - 95% d
  13. Please read the study results, focusing on the 95% Confidence Interval ranges. Note the fun & revealing study results, like: " ... for documented COVID infections ... 92% (95% CI, 88 to 95) " The key is the 1.2 million patients in the study. The big 1.2 million patient Israeli study, from the New England Journal of Medicine reports as low as 88% protection for some people, with a maximum of 95% protection of others - with an 'average' central value of 92% protection. If you know scientific reporting, you realize that a range of 88% to 95% with an average of 92% e
  14. Despite some claims that COVID vaccines supposedly protect us from serious COVID disease & hospitalization, there are proven gaps in the protection of all the COVID vaccines. Remember, when Pfizer reports an "average 92%" efficacy of protection, there are ½ the patients who had less than 92% protection. Note that the world's biggest study of Pfizer's vaccine by Israel's biggest healthcare provider, using 1.2 million patients, reported by the New England Journal of Medicine, reported up to a 22% risk of "severe COVID disease" for Pfizer vaccinated patients at 95% Confidence levels.
  15. The world's biggest study of Pfizer's vaccine by Israel's biggest healthcare provider, using 1.2 million patients, reported by the New England Journal of Medicine, reported up to a 22% risk of "severe COVID disease" for Pfizer vaccinated patients at 95% Confidence levels. The Israeli study further reported that up to 45% of the Pfizer vaccinated patients with "severe COVID disease" required hospitalization. ALL of the current vaccines have significant gaps in protection, ranging from a 12% gap in protection for Pfizer patients ... a 16% protection gap for Sinovac ... a 24% gap f
×
×
  • Create New...